RNU4-29P

Across TCGA pan-cancer cohorts, RNU4-29P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RNU4-29P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU4-29P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU4-29P expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.

BLCA, UVM, and LGG are the cancer types where RNU4-29P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.535	0.362	<.001	122	view →
UVM	DFS	Tertile	III,IV	0.189	0.876	<.001	60	view →
LGG	DFS	Median	All	0.768	0.883	<.001	48	view →
BRCA	OS	Median	All	0.979	0.946	<.001	46	view →
CESC	DFS	Tertile	III,IV	0.462	0.778	.011	30	view →
KIRP	DFS	Median	All	0.972	0.620	.004	22	view →
LUSC	DFS	Tertile	III,IV	0.215	0.799	.001	21	view →
READ	DFS	Tertile	III,IV	0.178	0.472	.002	18	view →
SKCM	DFS	Tertile	III,IV	0.126	0.435	.006	14	view →
UCS	DFS	Quartile	All	0.154	0.513	.003	12	view →
LUAD	DFS	Tertile	IV	0.420	0.798	.019	12	view →
KICH	OS	Quartile	III,IV	0.290	0.894	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RNU4-29P–BLCA (OS)

Open the BLCA breakdown →